These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1440406)

  • 1. [The therapeutic results in acute myeloid leukemias in elderly patients].
    Parovichnikova EN; Savchenko VG; Isaev VG; Tikhonova LIu; Sarycheva TG; Kulikov SM
    Ter Arkh; 1992; 64(8):87-9. PubMed ID: 1440406
    [No Abstract]   [Full Text] [Related]  

  • 2. [The results of 2 and 1/2 years of work of the Russian Multicenter Trial on the Treatment of Acute Myeloid Leukemias in Adults].
    Savchenko VG; Parovichnikova EN; Gliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS
    Ter Arkh; 1995; 67(7):8-12. PubMed ID: 7482315
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The results of a multicenter cooperative study on treating acute myeloid leukemias in adults].
    Savchenko VG; Parovichnikova EN; Kliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS
    Ter Arkh; 1994; 66(7):11-7. PubMed ID: 7985120
    [No Abstract]   [Full Text] [Related]  

  • 5. [The current chemotherapy of acute myeloid leukemias in adults].
    Poddubnaia IV; Perilov AA
    Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
    [No Abstract]   [Full Text] [Related]  

  • 6. New agents in the treatment of acute myeloid leukemia.
    Wiernik PH
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):95-8. PubMed ID: 1780763
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia.
    Siddiqui T; Durkin WJ; Conley NS; Doughney KB; Favis GR; Weiss R; Smith AE
    J Fla Med Assoc; 1994 Jul; 81(7):475-7. PubMed ID: 7964574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.
    Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Kanamaru A; Oh H; Ohtake S; Asou N; Sakamaki H; Yamada O; Jinnai I; Tsubaki K; Takeyama K; Hiraoka A; Matsuda S; Takahashi M; Shimazaki C; Adachi K; Kageyama S; Ohno R
    Int J Hematol; 1999 Aug; 70(2):97-104. PubMed ID: 10497848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Daunomycin-induced cardiogenic shock in a case of acute myelogenous leukemia].
    Matsuda S; Shineha H; Kokubun K; Yoshida M; Sakai K; Yui T; Kimura H; Uchida T; Kariyone S
    Rinsho Ketsueki; 1987 Sep; 28(9):1680-5. PubMed ID: 3481411
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction chemotherapy for acute myelogenous leukemia.
    Kalaycio M
    Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
    Kyo T; Dohy H
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
    [No Abstract]   [Full Text] [Related]  

  • 13. Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
    Leoni F; Ciolli S; Nozzoli C; Santini V; Fanci R; Rossi Ferrini P
    Haematologica; 2001 Jan; 86(1):104. PubMed ID: 11146581
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive individualized induction therapy with behenoyl cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults.
    Ohno R; Yokomaku S; Okumura M; Nagai T; Kitaori K; Ito T; Takeo T; Sugiura I; Yano K; Ito Y
    Int J Hematol; 1991 Dec; 54(6):487-93. PubMed ID: 1793832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol.
    Salooja N; Chatterjee R; McMillan AK; Kelsey SM; Newland AC; Milligan DW; Franklin IM; Hutchinson RM; Linch DC; Goldstone AH
    Bone Marrow Transplant; 1994 Apr; 13(4):431-5. PubMed ID: 8019467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3.
    Lichtman MA
    Blood Cells Mol Dis; 2013 Feb; 50(2):119-30. PubMed ID: 23154039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B.
    Mayer RJ; Davis RB; Schiffer CA; Berg DT; Sarno E; Frei E
    Leukemia; 1992; 6 Suppl 2():66-7. PubMed ID: 1578945
    [No Abstract]   [Full Text] [Related]  

  • 20. Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
    Harousseau JL; Milpied N; Briere J; Desablens B; Leprise PY; Ifrah N; Gandhour B; Casassus P
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):80-3. PubMed ID: 1780758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.